BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioAge Labs's enterprise value was -$50.03M on Nov 11, 2026, against $58.56M a year earlier. Over the last 2 years it ranged from -$211.05M to $705.89M, with a median of $5.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$50.03M | -126.0% |
| 2025 | Dec 31, 2025 | $192.64M | – |
| 2024 | Dec 31, 2024 | -$126.53M | – |
See a number that looks wrong?